Bowel Research UK partners with Symplectic Grant Tracker to advance life-changing research

Digital Science, a technology company serving stakeholders across the research ecosystem, is pleased to announce that Bowel Research UK (BRUK) has chosen Symplectic Grant Tracker from Digital Science's suite of flagship products to advance its aims of funding life-changing research into bowel cancer and other bowel diseases.

Designed from the outset to meet research funding needs, Symplectic Grant Tracker provides end-to-end grant management to foundations, charities and funders worldwide. Functionality includes intuitive form builder, multi-stage review and collaboration workflows, finance and budget tracking, contract and payment management, and support for integrated online committee meetings enabling live scoring and assessment during peer review.

BRUK typically holds two funding rounds per year; the first for PhDs, and the second for small grants. The charity's recently launched new 'Hard to Fund' Fund (HTFF) has been specially created to address the funding gap for bowel diseases and conditions that struggle for backing via conventional mechanisms.

Working with Symplectic Grant Tracker has streamlined our grants application process, with automation of various processes being key to saving us time. This has allowed us to focus our resources on other aspects of our research portfolio, such as developing initiatives like the 'Hard to Fund' Fund that invests in neglected topics within bowel research. The Grant Tracker team is always responsive and helpful, and we are grateful for their support as we have established this system within our organization."

Georgia Sturt, Research & Grants Manager at BRUK

"Bowel diseases and conditions affect a huge amount of people who are always seeking new treatments, cures, and ways to manage their condition," said Brian Armour, Solutions Consultant for Symplectic Grant Tracker. "We're excited by the opportunity to collaborate with Bowel Research UK and to support their grants lifecycle to ensure that funding for this life-changing research is allocated where it needs to be."